🩺NIH Notice of Closed Meeting on Grant Applications Review
The Department of Health and Human Services announces a closed meeting of the National Institute of Diabetes and Digestive and Kidney Diseases to review grant applications. The meeting will evaluate proposals related to diabetes, digestive diseases, and kidney diseases. The discussions are expected to involve confidential information, emphasizing the need for privacy and protection of intellectual property.
Learn More🏥Notice of Closed Meetings by National Heart, Lung, and Blood Institute
This document provides notice of closed meetings held by the National Heart, Lung, and Blood Institute under the Federal Advisory Committee Act. The meetings will focus on reviewing and evaluating contract proposals related to health and research, ensuring discussions remain confidential. The notice includes details on meeting times, contact information, and the significance of trade secrets involved.
Learn More💊Implications of New Nonprescription Drug Regulations for Businesses
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Learn More🚛FMCSA Notice on Drug Testing Exemption Renewal Application
FMCSA announces that it has received an application from DISA Entertainment Compliance Solutions (DECS), formerly known as Motion Picture Compliance Solutions, to renew its exemption from the requirement that an employer must not employ a driver who is subject to drug and alcohol testing to perform safety-sensitive functions prior to conducting a full query of the Drug and Alcohol Clearinghouse (Clearinghouse) on behalf of its members that employ commercial driver's license (CDL) holders. Under the requested exemption, DECS would conduct a limited query of the Clearinghouse before one of its member employers hires a driver for a project. If the limited query indicates that information about the driver exist in the Clearinghouse, the driver would not be permitted to perform safety-sensitive functions unless and until a full query subsequently shows that the driver is not prohibited from operating a commercial motor vehicle (CMV). FMCSA requests public comment on DECS' application for an exemption.
Learn More📚Executive Order 14242
Executive Order 14242 aims to improve educational outcomes by transferring authority from the federal government to states and local communities. The order highlights failures in federal education oversight, advocating for the closure of the Department of Education and promoting local control. It emphasizes the need for accountability and compliance in federal funding programs and the return of educational authority to state governance.
Learn More🛢️Advisory Bulletin on Pipeline Safety Management System Implementation
PHMSA is issuing this advisory bulletin to promote the implementation of a pipeline safety management system (PSMS) by regulated pipeline owners and operators.
Learn More⛏️Executive Order to Boost American Mineral Production
Executive Order 14241 calls for immediate actions to enhance domestic mineral production in the U.S. It outlines initiatives to streamline permitting processes, prioritize federal lands for mineral projects, and stimulate private-public investments, aiming to bolster the mineral sector and reduce reliance on foreign supplies.
Learn More🚆Proposed Regulatory Requirements for Railroad Workplace Safety
Under the Paperwork Reduction Act of 1995 (PRA) and its implementing regulations, FRA seeks approval of the Information Collection Request (ICR) summarized below. Before submitting this ICR to the Office of Management and Budget (OMB) for approval, FRA is soliciting public comment on specific aspects of the activities identified in the ICR.
Learn More🏥NIH Notice
The National Institutes of Health announces a closed meeting for the National Institute of Allergy and Infectious Diseases to evaluate contract proposals for developing diagnostics for Mycoplasma genitalium infection. The meeting focuses on contract discussions that may include sensitive trade secrets and personal information, reflecting the importance of confidentiality in health-related innovations.
Learn More🧠Change in Meeting Dates for NST-2 Study Section Notice
The Department of Health and Human Services announces an amendment to the meeting dates for the NST-2 Study Section of the National Institute of Neurological Disorders and Stroke. Originally scheduled for early April 2025, the meeting will now take place on April 21 and 22, 2025, but remains closed to the public.
Learn More